These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2718576)

  • 1. [The clinical significance of apolipoprotein determinations for assessment of the risk of atherosclerosis].
    Gehrisch S; Jaross W; Klement A; Gutschker A; Bergmann S
    Z Med Lab Diagn; 1989; 30(1):37-8. PubMed ID: 2718576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Rosenson RS
    N Engl J Med; 1992 Feb; 326(7):491; author reply 491-2. PubMed ID: 1732784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between leptin and lipids in atherosclerosis.
    Tamer L; Ercan B; Unlü A; Sucu N; Pekdemir H; Eskandari G; Atik U
    Indian Heart J; 2002; 54(6):692-6. PubMed ID: 12674182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High cholesterol level may protect against infections and probably also atherosclerosis].
    Ravnskov U
    Lakartidningen; 2004 Mar; 101(13):1215-7; discussion 1218, 1221-2. PubMed ID: 15101249
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids].
    Mordasini R; Riesen W
    Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood lipid and apolipoprotein concentrations in a healthy urban population of Northern Cameroon: variation with age and sex].
    Ndomou M; Ngogang J; Kenne M
    Sante; 1999; 9(3):169-72. PubMed ID: 10477406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
    Cabezas Castro M; Liem A
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gender-specific differences of risk factors of atherosclerosis. A study of 3,850 Vienna employees].
    Stelzeneder M; Weiss K; Katzenschlager R; Rauscha F; Richter H; Harmuth P; Pidlich J; Widhalm K; Sinzinger H
    Wien Med Wochenschr; 1993; 143(12):322-9. PubMed ID: 8212720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of plasma apolipoprotein B in myocardial infarction in young subjects. Correlations with coronarographic data].
    Douste-Blazy P; Solera ML; Delay M; De Graeve J; Valdiguie P; Marco J; Bernadet P
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):21-6. PubMed ID: 6422890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Myers RI
    N Engl J Med; 1992 Feb; 326(7):491; author reply 491-2. PubMed ID: 1732783
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Simon JA; Browner WS; Hulley SB
    N Engl J Med; 1992 Feb; 326(7):491; author reply 491-2. PubMed ID: 1580903
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood screening for the first markers of atherosclerosis. Diagnostic progress and therapeutic perspectives].
    Malmendier CL
    Bull Mem Acad R Med Belg; 1987; 142(1):168-74. PubMed ID: 3311257
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
    Walldius G; Jungner I
    Curr Opin Cardiol; 2007 Jul; 22(4):359-67. PubMed ID: 17556890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apolipoproteins as risk factors in patients on a regular hemodialysis program].
    Bokan L; Perunicić-Peković G; Rasić-Milutinović Z; Pljesa S; Tepsić V; Ristić V
    Med Pregl; 1997; 50(7-8):293-5. PubMed ID: 9441214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular analysis of atherogenic and protective lipoproteins].
    Fruchart JC; Bard JM; Fievet C; Puchois P
    Arch Mal Coeur Vaiss; 1987 Sep; 80 Spec No():13-6. PubMed ID: 2445318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.